AddLife AB (publ) (LON:0REZ)

Market Cap	1.42B -4.6%
Revenue (ttm)	826.40M -0.3%
Net Income	45.20M +83.8%
EPS	0.37 +84.1%
Shares Out	n/a
PE Ratio	31.46
Forward PE	n/a
Dividend	0.12 (0.08%)
Ex-Dividend Date	May 7, 2026

Volume	16,014
Average Volume	9,872
Open	145.40
Previous Close	146.80
Day's Range	145.40 - 148.30
52-Week Range	133.00 - 207.60
Beta	1.57
RSI	45.98
Earnings Date	Jul 16, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as w...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,295
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK